Skip to main content
Caplight Logo









Mana.bio

Mana.bio

Private
Tel AvivHealthcare & Life Scienceshttps://www.mana.bio/

Last Round

Seed

Oct 10, 2023

Total Funding Raised

$19.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mana.bio is a biotechnology company that operates an artificial intelligence-based drug delivery platform intended to facilitate lipid nanoparticle development for oligonucleotide therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

lipid nanoparticleLNPdrug deliverygenetic medicineAI drug discoverycomputational biologymRNA therapylarge language modelLLMbiotech AIin silico drug designnucleic acid deliveryAI agentpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mana.bio Comparables

Compare Mana.bio with similar companies based on industry and business-model similarity.

Mana.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mirai Bio
86%
Liberate Bio
85%
NanoPalm
82%

Mana.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 10, 2023

Key People

Founding team and executive leadership

Yogev Debbi

Co-Founder & CEO

Founding Team

Mana.bio Investors

Notable investors and investment history

Mana.bio investors
InvestorRounds
Andreessen HorowitzSeed
NFXSeed
TechnionSeed
Base4 CapitalSeed
LionBirdSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 5, representing 26% of headcount.

  • Sep 17, 2025

    Launched Mina, the world's first LLM for lipid nanoparticles.

Mana.bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mana.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mana.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range19
Year Founded2021
Last FundingOct 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?